ResMed Inc. (LON:0KW4)
252.97
+1.00 (0.40%)
At close: Jun 20, 2025
ResMed Revenue
ResMed had revenue of $1.29B USD in the quarter ending March 31, 2025, with 7.92% growth. This brings the company's revenue in the last twelve months to $5.02B, up 9.54% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
$5.02B
Revenue Growth
+9.54%
P/S Ratio
7.13
Revenue / Employee
$503.16K
Employees
9,980
Market Cap
27.71B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
ResMed News
- 15 days ago - ResMed: A Mixed Bag for Investors Amid Rising Competition - The Motley Fool
- 17 days ago - ResMed: A Sleeping Giant Hiding In Plain Sight - Seeking Alpha
- 24 days ago - Top 15 High-Growth Dividend Stocks For June 2025 - Seeking Alpha
- 6 weeks ago - Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 - GlobeNewsWire
- 7 weeks ago - Top 15 High-Growth Dividend Stocks To Consider For May 2025 - Seeking Alpha
- 2 months ago - Resmed Acquires VirtuOx - GlobeNewsWire
- 2 months ago - Billion-dollar medical start-ups say Trump could force a US move - The Australian Financial Review
- 2 months ago - We reaffirmed our tariff relief in 2008 and 2009, we went back again 3 weeks ago, says Resmed CEO - CNBC